JPH04282160A - Transfusion liquid container - Google Patents
Transfusion liquid containerInfo
- Publication number
- JPH04282160A JPH04282160A JP3068888A JP6888891A JPH04282160A JP H04282160 A JPH04282160 A JP H04282160A JP 3068888 A JP3068888 A JP 3068888A JP 6888891 A JP6888891 A JP 6888891A JP H04282160 A JPH04282160 A JP H04282160A
- Authority
- JP
- Japan
- Prior art keywords
- container
- drug
- vial
- flexible container
- infusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 51
- 229940079593 drug Drugs 0.000 claims abstract description 49
- 238000004891 communication Methods 0.000 claims description 47
- 238000001802 infusion Methods 0.000 claims description 44
- 239000003085 diluting agent Substances 0.000 claims description 4
- 239000011521 glass Substances 0.000 abstract description 2
- 229920003023 plastic Polymers 0.000 abstract description 2
- 239000004033 plastic Substances 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 32
- 229920005989 resin Polymers 0.000 description 10
- 239000011347 resin Substances 0.000 description 10
- 239000002775 capsule Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 3
- 239000003242 anti bacterial agent Substances 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 229920000092 linear low density polyethylene Polymers 0.000 description 2
- 239000004707 linear low-density polyethylene Substances 0.000 description 2
- 229920001684 low density polyethylene Polymers 0.000 description 2
- 239000004702 low-density polyethylene Substances 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 229920005672 polyolefin resin Polymers 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- JMMZCWZIJXAGKW-UHFFFAOYSA-N 2-methylpent-2-ene Chemical compound CCC=C(C)C JMMZCWZIJXAGKW-UHFFFAOYSA-N 0.000 description 1
- 229920000178 Acrylic resin Polymers 0.000 description 1
- 239000004925 Acrylic resin Substances 0.000 description 1
- 239000004709 Chlorinated polyethylene Substances 0.000 description 1
- GHASVSINZRGABV-UHFFFAOYSA-N Fluorouracil Chemical compound FC1=CNC(=O)NC1=O GHASVSINZRGABV-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 229960001931 ampicillin sodium Drugs 0.000 description 1
- KLOHDWPABZXLGI-YWUHCJSESA-M ampicillin sodium Chemical compound [Na+].C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C([O-])=O)(C)C)=CC=CC=C1 KLOHDWPABZXLGI-YWUHCJSESA-M 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940041181 antineoplastic drug Drugs 0.000 description 1
- 239000003699 antiulcer agent Substances 0.000 description 1
- 229960003408 cefazolin sodium Drugs 0.000 description 1
- FLKYBGKDCCEQQM-WYUVZMMLSA-M cefazolin sodium Chemical compound [Na+].S1C(C)=NN=C1SCC1=C(C([O-])=O)N2C(=O)[C@@H](NC(=O)CN3N=NN=C3)[C@H]2SC1 FLKYBGKDCCEQQM-WYUVZMMLSA-M 0.000 description 1
- 229960000636 ceftizoxime sodium Drugs 0.000 description 1
- ADLFUPFRVXCDMO-LIGXYSTNSA-M ceftizoxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=CCS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 ADLFUPFRVXCDMO-LIGXYSTNSA-M 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000013013 elastic material Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 229960001596 famotidine Drugs 0.000 description 1
- XUFQPHANEAPEMJ-UHFFFAOYSA-N famotidine Chemical compound NC(N)=NC1=NC(CSCCC(N)=NS(N)(=O)=O)=CS1 XUFQPHANEAPEMJ-UHFFFAOYSA-N 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 229960002949 fluorouracil Drugs 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960004857 mitomycin Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920006122 polyamide resin Polymers 0.000 description 1
- 229920005668 polycarbonate resin Polymers 0.000 description 1
- 239000004431 polycarbonate resin Substances 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920013716 polyethylene resin Polymers 0.000 description 1
- 229960001520 ranitidine hydrochloride Drugs 0.000 description 1
- GGWBHVILAJZWKJ-KJEVSKRMSA-N ranitidine hydrochloride Chemical compound [H+].[Cl-].[O-][N+](=O)\C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 GGWBHVILAJZWKJ-KJEVSKRMSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は、点滴注射に用いられる
輸液容器に関するものであり、医療の分野で用いられる
。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an infusion container used for drip injection, and is used in the medical field.
【0002】0002
【従来の技術】従来より、病院等の医療機関では、抗生
物質や抗癌剤等の粉末薬剤あるいは凍結乾燥薬剤を患者
に投与するには、バイアル等の容器に入ったこれらの薬
剤を溶解して点滴注射により行われていた。この場合、
上記薬剤の入った容器とその薬剤の溶解液の入った容器
とを両頭針或は連結管等の接続用具を用いて接続し、溶
解液を薬剤の入った容器に移し、薬剤を溶解している。
ところが、この操作は繁雑で手間がかかる上に、外気中
で薬剤の入った容器に接続用の穴をあける操作を行うの
で、中の薬剤が汚染される可能性がある。[Prior Art] Traditionally, in hospitals and other medical institutions, in order to administer powdered or freeze-dried drugs such as antibiotics and anticancer drugs to patients, these drugs are dissolved in containers such as vials and then infused. It was done by injection. in this case,
Connect the container containing the drug mentioned above and the container containing the solution of the drug using a connecting tool such as a double-ended needle or connecting tube, transfer the solution to the container containing the drug, and dissolve the drug. There is. However, this operation is complicated and time-consuming, and since the connection hole is made in the container containing the drug in the open air, there is a possibility that the drug inside may become contaminated.
【0003】そこで、上記の問題を解消したものとして
、特表昭61−501129 号公報に示されるような
輸液容器が提案されている。この輸液容器は、薬剤容器
であるバイアルを収容したカプセルと、薬液排出口を有
する溶解液の入った可撓性容器とが、チューブで接続さ
れたものである。前記チューブ内には、バイアル側に中
空の穿刺針が取り付けられ、可撓性容器側には破断部材
が取り付けられている。前記破断部材はチューブ内の通
路を閉じており、液体の流通を阻止している。[0003] In order to solve the above problem, an infusion container as shown in Japanese Patent Publication No. 1983-501129 has been proposed. This infusion container includes a capsule containing a vial serving as a drug container, and a flexible container containing a solution having a drug solution outlet, which are connected via a tube. Inside the tube, a hollow puncture needle is attached to the vial side, and a breaking member is attached to the flexible container side. The breaking member closes the passage within the tube and prevents the flow of liquid.
【0004】使用に際しては、カプセル内のバイアルを
押し下げ、穿刺針でバイアルのゴム栓を貫き、可撓性容
器とバイアルをまず連結し、次に、チューブ内の破断部
材を手で折り曲げ、それによりチューブ内の通路を開通
させ、薬剤と溶解液とを混合するようになっている。In use, the vial inside the capsule is pushed down, the puncture needle pierces the rubber stopper of the vial, the flexible container and the vial are first connected, and then the breakable member inside the tube is bent manually, thereby The passage within the tube is opened to mix the drug and the solution.
【0005】また、更に改良されたものとして、特開平
2−1277号公報に示されるような輸液容器が提案さ
れている。この輸液容器は、内部に溶解液または希釈液
が収納され、最上端に閉鎖体を有する液体通路部を有す
る可撓性容器と、前記可撓性容器に連結されたカプセル
と、口部が刺通可能な栓で密封されており前記カプセル
内に保持される薬剤容器と、前記可撓性容器の内部と薬
剤容器の内部とを連通する連通手段とからなり、前記連
通手段が中間にハブを有し両端に刃先を有する中空の穿
刺針と、前記穿刺針の一方の刃によって薬剤容器の栓が
刺通された後、穿刺針の他方の刃によって可撓性容器の
閉鎖体が刺通されるように連通順序を制御する制動手段
とからなっている。[0005] Furthermore, as a further improvement, an infusion container as shown in Japanese Unexamined Patent Publication No. 2-1277 has been proposed. This infusion container includes a flexible container containing a dissolving solution or a diluting solution and having a liquid passage section with a closure at the uppermost end, a capsule connected to the flexible container, and a mouth portion with a pierced opening. It consists of a drug container sealed with a passable stopper and held within the capsule, and a communication means for communicating the interior of the flexible container with the interior of the drug container, the communication means having a hub in the middle. a hollow puncture needle having cutting edges at both ends; and after the stopper of the drug container is pierced by one blade of the puncture needle, the closure of the flexible container is pierced by the other blade of the puncture needle. and a braking means for controlling the communication order so that the communication order is controlled.
【0006】[0006]
【発明が解決しようとする課題】しかしながら、特表昭
61−501129 号公報に示される輸液容器におい
て、薬剤容器と溶解液の入った可撓性容器とを連通して
混合する点に関しては、改良されたと言うものの、穿刺
針によってバイアルのゴム栓を刺通したのち、破断部材
を手で折って通路を開けなければならず、まだかなりの
手間を要するものである。また破断部材の折れ方が不完
全な場合には、液が通りにくく、溶解に時間がかかると
いう問題がある。また、特開平2−1277号公報に示
される輸液容器においては、薬剤容器と溶解液の入った
可撓性容器とを連通して混合する点及びそのときの操作
上の手間に関しては改良されたと言うものの、前記連通
手段が中間にハブを有し両端に刃先を有する中空の穿刺
針と、前記穿刺針の一方の刃によって薬剤容器の栓が刺
通された後、穿刺針の他方の刃によって可撓性容器の閉
鎖体が刺通されるように連通順序を制御するための複雑
な形状の制動手段が必要であり、製造コストが高くなる
という問題がある。[Problems to be Solved by the Invention] However, in the infusion container disclosed in Japanese Patent Publication No. 61-501129, improvements have been made in the point of communication between the drug container and the flexible container containing the solution. However, it still requires a considerable amount of time and effort, as the puncture needle must pierce the rubber stopper of the vial and then the breakable member must be manually broken to open the passage. Furthermore, if the breakable member is imperfectly bent, there is a problem in that it is difficult for the liquid to pass through and it takes a long time to dissolve. In addition, in the infusion container disclosed in JP-A-2-1277, improvements have been made in terms of the communication between the drug container and the flexible container containing the solution and the operational effort involved. However, the communication means includes a hollow puncture needle having a hub in the middle and cutting edges at both ends, and after the stopper of the drug container is pierced by one blade of the puncture needle, the other blade of the puncture needle pierces the stopper of the drug container. This requires a braking means with a complicated shape to control the communication order so that the closure of the flexible container is pierced, resulting in a problem of high manufacturing cost.
【0007】本発明は、このような問題に鑑みてなされ
たもので、薬剤容器と溶解液や希釈液(以下、溶解液と
いう)の容器との連通を確実かつ容易にし、連通後の薬
剤と溶解液の混合を短時間で行うことができ、可撓性容
器内の溶解液が連結体内に漏れることがない輸液容器を
提供することを目的とする。[0007] The present invention was made in view of these problems, and it ensures and facilitates communication between a drug container and a container for a solution or diluent (hereinafter referred to as a solution), and after communication, the drug and It is an object of the present invention to provide an infusion container that allows mixing of a solution in a short time and prevents the solution in a flexible container from leaking into a connecting body.
【0008】[0008]
【課題を解決するための手段】本発明の輸液容器は、連
結口部を有し内部に溶解液または希釈液が収納されてい
る可撓性容器と、前記可撓性容器に連結された連結体と
、前記連結体内に保持される口元部に栓体を有する薬剤
容器と、前記可撓性容器の内部と前記薬剤容器の内部と
を連通する連通具とからなり、前記栓体の連通具側に連
通具と容易に液密に接続することが可能な接続手段を栓
体と実質的に一体に形成したことを特徴とする。[Means for Solving the Problems] The infusion container of the present invention comprises a flexible container having a connecting port and containing a solution or diluent inside, and a connector connected to the flexible container. a medicine container having a stopper at the mouth portion held in the connecting body; and a communication device for communicating the inside of the flexible container and the inside of the drug container, the communication device for the stopper. It is characterized in that a connection means that can be easily and liquid-tightly connected to the communication tool is formed substantially integrally with the plug body on the side thereof.
【0009】[0009]
【作用】本発明においては、連通具と容易に液密に接続
することが可能な接続手段を設けることにより、連通具
は最初に薬剤容器の栓体に設けられた接続手段に連結さ
れ、その後、薬剤容器の栓体あるいは可撓性容器の閉鎖
体を貫通する。したがって、先に閉鎖体が貫通されてし
まい、可撓性容器内の溶解液や希釈液が連結体内に漏洩
してしまうという不都合が発生しない。[Operation] In the present invention, by providing a connecting means that can be easily and liquid-tightly connected to the communicating device, the communicating device is first connected to the connecting means provided on the stopper of the drug container, and then , through the stopper of a drug container or the closure of a flexible container. Therefore, the inconvenience that the closing body is penetrated first and the solution or diluent in the flexible container leaks into the connecting body does not occur.
【0010】また、連通手段として中空の連通具を用い
ており、連通具が薬剤容器の栓体と可撓性容器の閉鎖体
とを貫通することにより、直ちに連通する。中空の連通
具の連通であるので、液体の移動が円滑であり、かつ操
作ミスなどによって液体の移動が妨げられることがない
。したがって、連通後の薬剤と溶解液の混合を短時間で
行うことができる。[0010] Furthermore, a hollow communicating tool is used as the communicating means, and the communicating tool penetrates the stopper of the drug container and the closure of the flexible container, thereby immediately establishing communication. Since the communication is through a hollow communication device, the movement of the liquid is smooth, and the movement of the liquid is not hindered by operational errors or the like. Therefore, the drug and solution can be mixed in a short time after communication.
【0011】[0011]
【実施例】つぎに、本発明の実施例を説明する。図1は
本発明の一実施例にかかわる輸液容器の要部断面図、図
2は同実施例の輸液容器の連通具と接続手段が接続され
たところを示す要部断面図、図3は同実施例の輸液容器
が連通具により完全に連通されたところを示す要部断面
図、図4は接続手段の他の実施例を示す要部断面図、図
5は同実施例の輸液容器が連通具により完全に連通され
たところを示す要部断面図、図6は接続手段のさらに他
の実施例を示す要部断面図、図7は同実施例の輸液容器
が連通具により完全に連通されたところを示す要部断面
図、図8は接続手段のさらに他の実施例を示す要部断面
図、図9は同実施例の輸液容器が連通具により完全に連
通されたところを示す要部断面図、図10は図1に示し
た栓体の詳細断面図、図11は図4に示した栓体の詳細
断面図、図12は図6及び図8に示した栓体の詳細断面
図である。[Example] Next, an example of the present invention will be described. FIG. 1 is a cross-sectional view of a main part of an infusion container according to an embodiment of the present invention, FIG. 2 is a cross-sectional view of a main part of the infusion container of the same embodiment showing a connection between a communication tool and a connecting means, and FIG. A cross-sectional view of the essential parts showing the infusion container of the embodiment completely communicated with the communication device, FIG. 4 is a cross-sectional view of the main part showing another embodiment of the connecting means, and FIG. 5 shows the infusion container of the same embodiment in communication. FIG. 6 is a cross-sectional view of a main part showing still another embodiment of the connection means, and FIG. 7 is a cross-sectional view of a main part showing a state in which the infusion container of the same embodiment is completely communicated with a communication tool. FIG. 8 is a cross-sectional view of the main part showing still another embodiment of the connecting means, and FIG. 9 is a main part showing the infusion container of the same embodiment completely communicated with the communication device. 10 is a detailed sectional view of the plug shown in FIG. 1, FIG. 11 is a detailed sectional view of the plug shown in FIG. 4, and FIG. 12 is a detailed sectional view of the plug shown in FIGS. 6 and 8. It is.
【0012】図1に示す輸液容器は、薬剤容器1と可撓
性容器2と連通具3と連結体4とキャップ5から構成さ
れる。薬剤容器1は粉末薬剤或は凍結乾燥薬剤等の薬剤
を入れる容器(以下、バイアルという)である。バイア
ル1は公知のガラス製またはプラスチック製のバイアル
であり、その口元部6は栓体7で密封され、口元部6が
下になるように連結体4に収納されている。The infusion container shown in FIG. 1 is composed of a drug container 1, a flexible container 2, a communicating device 3, a connector 4, and a cap 5. The drug container 1 is a container (hereinafter referred to as a vial) that holds a drug such as a powdered drug or a freeze-dried drug. The vial 1 is a well-known glass or plastic vial, the mouth part 6 of which is sealed with a stopper 7, and is housed in the connector 4 with the mouth part 6 facing down.
【0013】可撓性容器2は、溶解液を入れる容器で、
低密度ポリエチレン樹脂、直鎖状低密度ポリエチレン樹
脂、ポリプロピレン樹脂、軟質ポリエステル樹脂、塩素
化ポリエチレン樹脂、塩化ビニル樹脂、エチレン−酢酸
ビニル共重合体等の可撓性に富んだ材料で形成されてい
る。なかでも、低密度ポリエチレン樹脂、直鎖状低密度
ポリエチレン樹脂、ポリプロピレン樹脂等のポリオレフ
ィン系樹脂は、耐薬品性に優れ、溶解液中への溶出物も
少なく、廉価であり経済性に優れているので好ましい。
可撓性容器2の上端には連結口部8が形成されており、
また下端には薬液排出口部9が形成されている。連結口
部8は閉鎖体10により密封されている。本実施例にお
いては、閉鎖体10はゴム状弾性体で形成された栓を用
いているが、その他の形態の栓であってもよい。[0013] The flexible container 2 is a container for containing a solution.
Made of highly flexible materials such as low-density polyethylene resin, linear low-density polyethylene resin, polypropylene resin, soft polyester resin, chlorinated polyethylene resin, vinyl chloride resin, and ethylene-vinyl acetate copolymer. . Among these, polyolefin resins such as low-density polyethylene resin, linear low-density polyethylene resin, and polypropylene resin have excellent chemical resistance, have little elution into the solution, are inexpensive, and have excellent economic efficiency. Therefore, it is preferable. A connecting mouth portion 8 is formed at the upper end of the flexible container 2.
Further, a chemical liquid discharge port 9 is formed at the lower end. The connecting port 8 is sealed by a closing body 10. In this embodiment, the closure body 10 uses a plug made of a rubber-like elastic material, but other types of plugs may be used.
【0014】バイアル1を収納している連結体4は、そ
の上端は開放されており、その下端は連結口部8と接合
されている。この連結体4により、連結体4に収納され
ているバイアル1と可撓性容器2が連結されている。連
結体4は、ポリオレフィン系樹脂やスチレン系樹脂やア
クリル系樹脂やポリカーボネート樹脂やポリアミド系樹
脂等で形成されている。なかでも、紫外線を比較的透過
し易いポリプロピレン樹脂やメチルペンテン樹脂等を用
いれば、連結体4の外部から紫外線を照射することによ
り連結体4の内部を滅菌することができるので、滅菌が
容易になり好ましい。また、連結体4の上端にはキャッ
プ5が被冠されている。このキャップ5は、バイアル1
を無菌的に保護するとともに、バイアル1を押し下げる
働きをするものであり、種々の構造のものを用いること
ができる。更に、キャップ5の上面に懸架手段11を設
けることにより、本発明による輸液容器をガードル台等
に引っ掛けて用いることができる。The connecting body 4 housing the vial 1 has an open upper end and a lower end connected to the connecting opening 8. This connecting body 4 connects the vial 1 and the flexible container 2 housed in the connecting body 4. The connecting body 4 is made of polyolefin resin, styrene resin, acrylic resin, polycarbonate resin, polyamide resin, or the like. Among these, by using polypropylene resin, methylpentene resin, etc., which are relatively easy to transmit ultraviolet rays, the inside of the connecting body 4 can be sterilized by irradiating ultraviolet rays from the outside of the connecting body 4, so sterilization can be easily performed. It's very desirable. Further, the upper end of the connecting body 4 is covered with a cap 5. This cap 5 is attached to vial 1
It functions to protect the vial 1 in a sterile manner and to push down the vial 1, and various structures can be used. Further, by providing a suspension means 11 on the upper surface of the cap 5, the infusion container according to the present invention can be used by being hung on a girdle stand or the like.
【0015】図1に示した連通具3は、中空管としての
中空状の穿刺針12と穿刺針保持部材13で構成され、
穿刺針12は穿刺針保持部材13に固定されたものを一
例として挙げた。連通具3は連結体4の下端部の口元部
6と連結口部8の間に移動可能な状態で設置されている
。The communication device 3 shown in FIG. 1 is composed of a hollow puncture needle 12 as a hollow tube and a puncture needle holding member 13.
As an example, the puncture needle 12 is fixed to the puncture needle holding member 13. The communication tool 3 is movably installed between the mouth part 6 and the connection mouth part 8 at the lower end of the connecting body 4.
【0016】本発明において、バイアル1に入れられる
薬剤の一例としては、セファゾリンナトリウムやセフチ
ゾキシムナトリウム等のセフェム系抗生物質、アンピシ
リンナトリウムやカルペニシリンナトリウム等のペニシ
リン系抗生物質、マイトマイシンCやフルオロウラシル
等の抗腫瘍剤、ファモチジンや塩酸ラニチジン等の抗潰
瘍剤、ウロキナーゼ等の血栓溶解剤などがある。In the present invention, examples of drugs to be placed in the vial 1 include cephalic antibiotics such as cefazolin sodium and ceftizoxime sodium, penicillin antibiotics such as ampicillin sodium and carpenicillin sodium, mitomycin C and fluorouracil. anti-ulcer agents such as famotidine and ranitidine hydrochloride, and thrombolytic agents such as urokinase.
【0017】可撓性容器2に入れられる溶解液の一例と
しては、生理食塩水、5%ブドウ糖液、注射用蒸留水の
ほか、各種電解質を含む溶液等が挙げられる。Examples of the solution to be placed in the flexible container 2 include physiological saline, 5% glucose solution, distilled water for injection, and solutions containing various electrolytes.
【0018】図1に示す薬剤容器の栓体7は、連通具3
に面する側に凹状の空洞を形成した接続手段14を有し
ている。接続手段14の入口近傍には環状リブ15が設
けられている。環状リブ15の内径は穿刺針12の外径
より少し小さくしてある。The stopper 7 of the medicine container shown in FIG.
It has a connecting means 14 having a concave cavity formed on the side facing. An annular rib 15 is provided near the entrance of the connecting means 14 . The inner diameter of the annular rib 15 is made slightly smaller than the outer diameter of the puncture needle 12.
【0019】次に、本発明の輸液容器が連通具により連
通される状態を説明する。まず、キャップ5で、バイア
ル1を押し下げると、連通具3のバイアル側の穿刺針と
バイアルの栓体に設けられた接続手段14とが接続され
る。そのときの状態を図2に示す。キャップ5でバイア
ル1を押し下げると、バイアルの栓体7と穿刺針12が
接続手段14において接触しする。更に、キャップ5で
バイアル1を押し下げると栓体7によって連通具3が押
し下げられ、連通具3は可撓性容器の閉鎖体10の方に
移動し、連結口部8側の穿刺針12が可撓性容器の閉鎖
体10に突き当たる。次に、穿刺針12が接続手段14
に挿入される抵抗と穿刺針12が閉鎖体10を刺通する
抵抗を比較すると、穿刺針12が接続手段14に挿入さ
れる抵抗のほうが遥かに小さいので穿刺針12と接続手
段14が先に接続されることになる。このとき、接続手
段14の空洞の内径を穿刺針12の外径よりも大きくし
、 環状リブ15の内径を穿刺針の外径よりも小さくす
ることにより、 穿刺針12の接続手段14への挿入抵
抗を小さくでき、かつ穿刺針12と接続手段14を液密
に接続することが容易になる。Next, a state in which the infusion container of the present invention is communicated with the communication device will be explained. First, when the vial 1 is pushed down with the cap 5, the puncture needle on the vial side of the communication device 3 and the connecting means 14 provided on the stopper of the vial are connected. The state at that time is shown in FIG. When the vial 1 is pushed down with the cap 5, the stopper 7 of the vial and the puncture needle 12 come into contact at the connecting means 14. Further, when the vial 1 is pushed down with the cap 5, the communicating device 3 is pushed down by the stopper 7, and the communicating device 3 moves toward the closure body 10 of the flexible container, and the puncture needle 12 on the connecting opening 8 side is opened. It hits the closure 10 of the flexible container. Next, the puncture needle 12 is connected to the connecting means 14
Comparing the resistance when the puncture needle 12 is inserted into the closure body 10 and the resistance when the puncture needle 12 is inserted into the connecting means 14, the resistance when the puncture needle 12 is inserted into the connecting means 14 is much smaller, so the puncture needle 12 and the connecting means 14 are inserted first. It will be connected. At this time, by making the inner diameter of the cavity of the connecting means 14 larger than the outer diameter of the puncture needle 12 and the inner diameter of the annular rib 15 smaller than the outer diameter of the puncture needle, the puncture needle 12 can be inserted into the connecting means 14. The resistance can be reduced, and the puncture needle 12 and the connecting means 14 can be easily connected in a liquid-tight manner.
【0020】さらに、キャップ5で、バイアル1を押し
下げると、穿刺針12は栓体7と閉鎖体10を刺通する
。これにより、バイアル1の内部と可撓性容器2の内部
は連通具3によって連通される。このときの状態を図3
に示す。このとき、穿刺針12が栓体7あるいは閉鎖体
10のどちらを先に貫通してもかまわない。なぜなら、
既に穿刺針12と栓体の接続手段14が接続されている
ので、閉鎖体10を先に貫通しても可撓性容器2内の溶
解液が連結体4内に漏洩することはないからである。Further, when the vial 1 is pushed down with the cap 5, the puncture needle 12 pierces the stopper 7 and the closure 10. Thereby, the inside of the vial 1 and the inside of the flexible container 2 are communicated with each other through the communication tool 3. Figure 3 shows the state at this time.
Shown below. At this time, it does not matter which of the plug body 7 or the closure body 10 the puncture needle 12 penetrates first. because,
Since the puncture needle 12 and the plug connecting means 14 are already connected, the solution in the flexible container 2 will not leak into the connecting body 4 even if the closure body 10 is penetrated first. be.
【0021】このようにして、バイアル1と可撓性容器
2とが連通すると、可撓性容器2を圧迫したり、もんだ
りして内部の溶解液の一部をバイアル1内に送り込み、
バイアル1内の薬剤を溶解する。そして、再び可撓性容
器2を圧迫したり、もんだりすると、バイアル1内の薬
液は、可撓性容器2内に戻る。戻された薬液は可撓性容
器2の薬液排出口部9に輸液セットなどを接続して輸液
として用いられる。[0021] When the vial 1 and the flexible container 2 are brought into communication in this manner, the flexible container 2 is squeezed or kneaded to send a portion of the solution inside into the vial 1.
Dissolve the drug in vial 1. Then, when the flexible container 2 is pressed or squeezed again, the drug solution in the vial 1 returns to the flexible container 2. The returned medicinal solution is used as an infusion by connecting an infusion set or the like to the medicinal solution outlet 9 of the flexible container 2.
【0022】次に本発明の他の実施例を図4及び図5に
基づいて説明する。栓体27は連通具3側に突起状の接
続手段24を有する。突起状の接続手段24の内部は図
1に示した栓体7の接続手段と同様に空洞になっており
、また環状リブ25を有している。本実施例においては
、予め穿刺針12と接続手段24が接続されている。こ
のときの状態を図4に示す。次に、本発明の輸液容器を
連通具により連通させる方法は、前記実施例と実質的に
同じである。
すなわち、キャップ5で、バイアル1を押し下げると、
穿刺針12は栓体7と閉鎖体10を刺通する。これによ
り、バイアル1の内部と可撓性容器2の内部は連通具3
によって連通される。このときの状態を図5に示す。こ
のとき、穿刺針12が栓体7あるいは閉鎖体10のどち
らを先に貫通してもかまわない。なぜなら、既に穿刺針
12と栓体の接続手段14が接続されているので、閉鎖
体10を先に貫通しても可撓性容器2内の溶解液が連結
体4内に漏洩することはないからである。同実施例にお
いては、予め穿刺針12と接続手段24が接続されてい
るが、図1に示した実施例と同様に、穿刺針12と接続
手段24が予め接続されていないものでも、穿刺針12
が閉鎖体10を刺通する抵抗よりも穿刺針12が接続手
段24に挿入される抵抗のほうが遥かに小さいので図1
に示した実施例と同じ効果が得られる。Next, another embodiment of the present invention will be explained based on FIGS. 4 and 5. The plug body 27 has a protruding connecting means 24 on the communicating device 3 side. The inside of the protruding connecting means 24 is hollow like the connecting means of the stopper 7 shown in FIG. 1, and has an annular rib 25. In this embodiment, the puncture needle 12 and the connecting means 24 are connected in advance. The state at this time is shown in FIG. Next, the method for communicating the infusion container of the present invention using the communication device is substantially the same as in the above embodiment. That is, when you push down the vial 1 with the cap 5,
The puncture needle 12 pierces the plug body 7 and the closure body 10. As a result, the inside of the vial 1 and the inside of the flexible container 2 are connected to the communication tool 3.
communicated by. The state at this time is shown in FIG. At this time, it does not matter which of the plug body 7 or the closure body 10 the puncture needle 12 penetrates first. This is because the puncture needle 12 and the plug connecting means 14 are already connected, so even if the closure body 10 is penetrated first, the solution in the flexible container 2 will not leak into the connecting body 4. It is from. In this embodiment, the puncture needle 12 and the connecting means 24 are connected in advance, but as in the embodiment shown in FIG. 12
Since the resistance to inserting the puncture needle 12 into the connecting means 24 is much smaller than the resistance to piercing the closure body 10, the resistance shown in FIG.
The same effects as in the embodiment shown in can be obtained.
【0023】さらに、本発明の他の実施例を図6及び図
7に基づいて説明する。栓体37は予め貫通路32が形
成されており、貫通路32は、ほぼ球状の遮蔽体33に
よって密閉されている。この貫通路が本発明で言う接続
手段になる。すなわち、貫通路32の内径を連通具3の
中空管42の外径よりも大きくし、 中空管42の外径
よりも小さい内径の環状リブ35を連通具3側の貫通路
の入口近傍に設置する。本実施例においては、予め中空
管42と接続手段である貫通路32が接続されている。
このときの状態を図6に示す。本発明の輸液容器を連通
具により連通させる方法は、前記実施例と実質的に同じ
である。すなわち、キャップ5で、バイアル1を押し下
げると、中空管42は遮蔽体33を貫通路32からバイ
アル1内に押出し、穿刺針43は閉鎖体10を刺通する
。これにより、バイアル1の内部と可撓性容器2の内部
は連通具3によって連通される。このときの状態を図7
に示す。このとき、中空管42が遮蔽体33を貫通路3
2からバイアル1内に押出し貫通させるのと穿刺針43
が閉鎖体10を貫通するのとが、どちらが先に行われて
ももかまわない。なぜなら、既に中空管42は栓体の接
続手段である貫通路32に接続されているので、閉鎖体
10を先に貫通しても可撓性容器2内の溶解液が連結体
4内に漏洩することはないからである。同実施例におい
ては、予め中空管42と接続手段である貫通路32が接
続されているが、図1に示した実施例と同様に、中空管
42と栓体の接続手段である貫通路32が予め接続され
ていないものでも、穿刺針43が閉鎖体10を刺通する
抵抗よりも中空管42が貫通路32に挿入される抵抗の
ほうが遥かに小さいので図1に示した実施例と同じ効果
が得られる。Further, another embodiment of the present invention will be explained based on FIGS. 6 and 7. A through passage 32 is formed in the plug body 37 in advance, and the through passage 32 is sealed by a substantially spherical shielding body 33. This through path becomes the connection means referred to in the present invention. That is, the inner diameter of the through passage 32 is made larger than the outer diameter of the hollow tube 42 of the communicating tool 3, and the annular rib 35 having an inner diameter smaller than the outer diameter of the hollow tube 42 is placed near the entrance of the through passage on the communicating implement 3 side. to be installed. In this embodiment, the hollow pipe 42 and the through passage 32, which is a connecting means, are connected in advance. The state at this time is shown in FIG. The method of communicating the infusion container of the present invention with the communication device is substantially the same as in the embodiment described above. That is, when the vial 1 is pushed down with the cap 5, the hollow tube 42 pushes out the shield 33 from the through passage 32 into the vial 1, and the puncture needle 43 pierces the closure body 10. Thereby, the inside of the vial 1 and the inside of the flexible container 2 are communicated with each other through the communication tool 3. Figure 7 shows the state at this time.
Shown below. At this time, the hollow tube 42 passes through the shield 33 through the passage 3.
2 into the vial 1 and penetrate the puncture needle 43.
It does not matter which is done first, that is, the penetrating body 10 is penetrated through the closure body 10. This is because the hollow tube 42 is already connected to the through passage 32 which is the connection means of the stopper, so even if the closure body 10 is penetrated first, the solution in the flexible container 2 will not flow into the connecting body 4. This is because there will be no leakage. In this embodiment, the hollow pipe 42 and the through-hole 32, which is a connecting means, are connected in advance, but similarly to the embodiment shown in FIG. Even if the channel 32 is not connected in advance, the resistance to the hollow tube 42 being inserted into the through channel 32 is much smaller than the resistance to the puncture needle 43 penetrating the closure body 10, so the implementation shown in FIG. The same effect as the example is obtained.
【0023】さらに、本発明の他の実施例を図8及び図
9に基づいて説明する。バイアル1に用いる栓体として
は上記実施例で用いた栓体37を用い、可撓性容器2の
閉鎖体にも、栓体37と同様な貫通路52と遮蔽体53
で構成される閉鎖体50を用いている。本実施例におい
ては、予め連通具の中空管42と接続手段である貫通路
32が接続されている。このときの状態を図8に示す。
本発明の輸液容器を連通具により連通させる方法は、前
記実施例と実質的に同じである。すなわち、キャップ5
で、バイアル1を押し下げると、中空管42は遮蔽体3
3を貫通路32からバイアル1内に押し出し、他方の中
空管42は閉鎖体50の遮蔽体53を貫通路52から可
撓性容器2内に押し出す。これにより、バイアル1の内
部と可撓性容器2の内部は連通具3によって連通される
。このときの状態を図9に示す。このとき、中空管42
が遮蔽体33を貫通路32からバイアル1内に押し出し
貫通させるのと他方の中空管42が閉鎖体50の遮蔽体
53を貫通路52から可撓性容器2内に押し出すのとが
、どちらが先に行われてもかまわない。なぜなら、既に
中空管42と栓体の接続手段である貫通路32が接続さ
れているので、閉鎖体50を先に貫通しても可撓性容器
2内の溶解液が連結体4内に漏洩することはないからで
ある。Further, another embodiment of the present invention will be explained based on FIGS. 8 and 9. The closure body 37 used in the above embodiment is used as the closure body for the vial 1, and the closure body of the flexible container 2 also has a through passage 52 and a shield 53 similar to the closure body 37.
A closed body 50 composed of is used. In this embodiment, the hollow tube 42 of the communication device and the through passage 32 serving as the connecting means are connected in advance. The state at this time is shown in FIG. The method of communicating the infusion container of the present invention with the communication device is substantially the same as in the embodiment described above. That is, cap 5
Then, when the vial 1 is pushed down, the hollow tube 42 closes to the shield 3.
3 into the vial 1 through the passageway 32, and the other hollow tube 42 pushes out the shield 53 of the closure body 50 through the passageway 52 into the flexible container 2. Thereby, the inside of the vial 1 and the inside of the flexible container 2 are communicated with each other through the communication tool 3. The state at this time is shown in FIG. At this time, the hollow tube 42
which is the case where the shield 33 is pushed out from the through passage 32 into the vial 1 and the other hollow tube 42 pushes the shield 53 of the closure body 50 from the through passage 52 into the flexible container 2. It doesn't matter if it is done first. This is because the hollow tube 42 and the through-hole 32, which is the connecting means for the stopper, are already connected, so even if the closing body 50 is penetrated first, the solution in the flexible container 2 will not flow into the connecting body 4. This is because there will be no leakage.
【0024】同実施例においては、予め中空管42と栓
体の接続手段である貫通路32が接続されているが、図
1に示した実施例と同様に、中空管42と栓体の接続手
段である貫通路32が接続されていないものでも、貫通
路32に設ける環状リブと中空管42との挿入抵抗より
貫通路52に設ける環状リブと中空管42との挿入抵抗
を大きくすることにより、あるいは貫通路52に環状リ
ブを設けずに貫通路52の内径を中空管42の外径より
も小さくして中空管42の貫通路52への挿入抵抗を貫
通路32に設ける環状リブと中空管42との挿入抵抗よ
り大きくすることにより同じ効果が得られる。In this embodiment, the hollow tube 42 and the plug are connected in advance to the through passage 32, which is a connecting means, but similarly to the embodiment shown in FIG. Even if the through passage 32 is not connected, the insertion resistance between the annular rib provided in the through passage 52 and the hollow tube 42 is lower than the insertion resistance between the annular rib provided in the through passage 32 and the hollow tube 42 The insertion resistance of the hollow tube 42 into the through passage 52 can be reduced by making the through passage 52 larger, or by not providing an annular rib in the through passage 52 and making the inner diameter of the through passage 52 smaller than the outer diameter of the hollow tube 42. The same effect can be obtained by making the insertion resistance greater than that between the annular rib and the hollow tube 42.
【0025】更に、同実施例において、予め中空管42
と栓体の接続手段である貫通路32を接続し、かつ中空
管42と閉鎖体50の貫通路52を接続しておく実施形
態も可能であることは明らかである。Furthermore, in the same embodiment, the hollow tube 42 is
It is clear that an embodiment is also possible in which the through passage 32, which is the connecting means of the plug body, is connected to the hollow tube 42 and the through passage 52 of the closure body 50 is connected.
【0026】以上に種々の実施例を説明したが、本発明
はその要旨を逸脱しない範囲で種々の変更例を採用する
ことができる。Although various embodiments have been described above, various modifications can be made to the present invention without departing from the gist thereof.
【0027】[0027]
【発明の効果】以上説明したように本発明の輸液容器は
、薬剤容器(バイアル)の栓体と可撓性容器の閉鎖体の
貫通順序を制御しなくても、可撓性容器内の溶解液等の
漏洩が生じない。また、中空状の連通具を用いることに
より可撓性容器内の溶解液等の移動が円滑であり、バイ
アル内の薬剤と溶解液の混合が短時間に実施できる。Effects of the Invention As explained above, the infusion container of the present invention can prevent dissolution in the flexible container without controlling the order of penetration of the stopper of the drug container (vial) and the closure of the flexible container. No leakage of liquid, etc. occurs. Furthermore, by using the hollow communication device, the solution, etc. in the flexible container can be smoothly moved, and the drug and solution in the vial can be mixed in a short time.
【図1】本発明による輸液容器の一実施例を示す要部断
面図である。FIG. 1 is a sectional view of a main part showing an embodiment of an infusion container according to the present invention.
【図2】同実施例の輸液容器の連通具と接続手段が連通
されたところを示す要部断面図である。FIG. 2 is a cross-sectional view of a main part showing a place where a communicating device and a connecting means of the infusion container of the same embodiment are communicated with each other.
【図3】同実施例の輸液容器が連通具により完全に連通
されたところを示す要部断面図である。FIG. 3 is a cross-sectional view of the essential parts of the infusion container of the same embodiment, showing the infusion container completely communicated with the communication device.
【図4】本発明による輸液容器に用いられる栓体の接続
手段の他の実施例を示す要部断面図である。FIG. 4 is a sectional view of a main part showing another embodiment of a connecting means for a stopper used in an infusion container according to the present invention.
【図5】同実施例の輸液容器が連通具により完全に連通
されたところを示す要部断面図である。FIG. 5 is a cross-sectional view of the essential parts of the infusion container of the same embodiment, showing the infusion container completely communicated with the communication device.
【図6】本発明による輸液容器に用いられる栓体の接続
手段のさらに他の実施例を示す要部断面図である。FIG. 6 is a cross-sectional view of a main part showing still another embodiment of the connection means of the stopper used in the infusion container according to the present invention.
【図7】同実施例の輸液容器が連通具により完全に連通
されたところを示す要部断面図である。FIG. 7 is a sectional view of a main part of the infusion container of the same embodiment, showing the infusion container completely communicated with the communication device.
【図8】本発明による輸液容器に用いられる栓体の接続
手段のさらに他の実施例を示す要部断面図である。FIG. 8 is a cross-sectional view of a main part showing still another embodiment of a connecting means for a stopper used in an infusion container according to the present invention.
【図9】同実施例の輸液容器が連通具により完全に連通
されたところを示す要部断面図である。FIG. 9 is a cross-sectional view of the essential parts of the infusion container of the same embodiment, showing the infusion container completely communicated with the communication device.
【図10】図1に示した実施例に用いられた栓体の詳細
断面図である。FIG. 10 is a detailed sectional view of the plug used in the embodiment shown in FIG. 1;
【図11】図4に示した実施例に用いられた栓体の詳細
断面図である。FIG. 11 is a detailed sectional view of the plug used in the embodiment shown in FIG. 4;
【図12】図6及び図8に示した実施例に用いられた栓
体の詳細断面図である。12 is a detailed sectional view of the plug used in the embodiment shown in FIGS. 6 and 8. FIG.
1 薬剤容器(バイアル) 2 可撓性容器 3 連通具 4 連結体 5 キャップ 6 口元部 7 栓体 8 連結口部 9 薬液排出口部 10 閉鎖体 11 懸架手段 12 穿刺針 13 穿刺針保持部材 14 接続手段 15 環状リブ 24 接続手段 25 環状リブ 27 栓体 32 貫通路 33 遮蔽体 35 環状リブ 37 栓体 42 中空管 43 穿刺針 50 閉鎖体 52 貫通路 53 遮蔽体 1. Drug container (vial) 2. Flexible container 3. Communication tool 4 Connected body 5 Cap 6 Mouth area 7 Plug body 8 Connection opening 9 Chemical solution outlet part 10 Closed body 11 Suspension means 12 Puncture needle 13 Puncture needle holding member 14 Connection means 15 Annular rib 24 Connection means 25 Annular rib 27 Plug body 32 Penetration path 33 Shield 35 Annular rib 37 Plug body 42 Hollow tube 43 Puncture needle 50 Closed body 52 Penetration path 53 Shield
Claims (7)
釈液が収納されている可撓性容器と、前記可撓性容器に
連結された連結体と、前記連結体内に保持される口元部
に栓体を有する薬剤容器と、前記可撓性容器の内部と前
記薬剤容器の内部とを連通する連通具とからなり、前記
栓体の連通具側に連通具と容易に液密に接続することが
可能な接続手段を栓体と実質的に一体に形成したことを
特徴とする輸液容器。1. A flexible container having a connecting opening and storing a solution or diluent therein, a connecting body connected to the flexible container, and a mouth held in the connecting body. A drug container having a stopper at a portion thereof, and a communication tool that communicates the inside of the flexible container with the inside of the drug container, and easily liquid-tightly connected to the communication tool on the communication tool side of the stopper. 1. An infusion container characterized in that a connection means capable of connecting is formed substantially integrally with a stopper.
状の空洞であり、前記空洞に内径が前記連通具の外径よ
り小さい環状リブを有することを特徴とする請求項1記
載の輸液容器。2. The infusion container according to claim 1, wherein the connecting means is a concave cavity formed of an elastic body, and the cavity has an annular rib whose inner diameter is smaller than the outer diameter of the communication device. .
されていることを特徴とする請求項1記載の輸液容器。3. The infusion container according to claim 1, wherein the communication device is connected to the connection means in advance.
請求項1記載の輸液容器。4. The infusion container according to claim 1, wherein the drug container is a drug vial.
に薬液排出口部を有する請求項4記載の輸液容器。5. The infusion container according to claim 4, wherein the flexible container has a drug solution outlet in addition to the connecting port.
ためのキャップが気密に被冠されてなる請求項1記載の
輸液容器。6. The infusion container according to claim 1, wherein the connector is airtightly covered with a cap for lowering the drug container.
る中空管である請求項1記載の輸液容器。7. The infusion container according to claim 1, wherein the communication device is a hollow tube having a holding member in the middle.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3068888A JPH04282160A (en) | 1991-03-08 | 1991-03-08 | Transfusion liquid container |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3068888A JPH04282160A (en) | 1991-03-08 | 1991-03-08 | Transfusion liquid container |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04282160A true JPH04282160A (en) | 1992-10-07 |
Family
ID=13386646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3068888A Pending JPH04282160A (en) | 1991-03-08 | 1991-03-08 | Transfusion liquid container |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04282160A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995000101A1 (en) * | 1993-06-28 | 1995-01-05 | Roussel Morishita Co., Ltd. | Medical container |
US5445631A (en) * | 1993-02-05 | 1995-08-29 | Suntory Limited | Fluid delivery system |
-
1991
- 1991-03-08 JP JP3068888A patent/JPH04282160A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5445631A (en) * | 1993-02-05 | 1995-08-29 | Suntory Limited | Fluid delivery system |
WO1995000101A1 (en) * | 1993-06-28 | 1995-01-05 | Roussel Morishita Co., Ltd. | Medical container |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH05212090A (en) | Transfusion container | |
KR960005814B1 (en) | Infusion container | |
US10806668B2 (en) | Method and assembly for fluid transfer and drug containment in an infusion system | |
KR950012185B1 (en) | Transfusion device | |
KR100569223B1 (en) | Integrated infusion container | |
EP0503867B1 (en) | storing and mixing apparatus | |
EP0598918A1 (en) | Medical container | |
JP2009536085A (en) | Vented infusion access device | |
KR100198363B1 (en) | Drug vessel | |
JP2012010930A (en) | Medicine administration appliance | |
KR950003690B1 (en) | Fluid containcr | |
JP2000070336A (en) | Medicinal liquid storage container and medicinal liquid injecting set using the container | |
JP4552271B2 (en) | Liquid transfer tool | |
JPH0642676Y2 (en) | Infusion bag | |
JPH04282160A (en) | Transfusion liquid container | |
JPH07171192A (en) | Infusion vessel | |
JP2630185B2 (en) | Infusion device | |
JP3109850B2 (en) | Infusion container | |
JPH04329957A (en) | Germ-free holding/mixing apparatus for two kinds of medicines held in individually sealed container | |
JP2710414B2 (en) | Injection solution dissolver | |
JP3238170B2 (en) | Infusion container | |
JP3467758B2 (en) | Drug transfer device for dissolving protein preparations | |
JPH0642675Y2 (en) | Medical bag | |
JPH04329953A (en) | Gear free holding/mixing apparatus for two kinds of medicines held in individually sealed container | |
JPH07112015A (en) | Liquid communicating tube |